Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Track all the latest updates and news of Gland Pharma IPO.
November 4, 2020 10:42:00 AM
The IPO of Hyderabad-based Gland Pharma will open on November 9 and close on November 11. The company plans to raise up to ?1,250 crore through issue of fresh equity shares up to 34.8 lakh.
Published by : Business Insider IndiaNovember 8, 2020 1:53:00 PM
Gland Pharma is set to open its initial public offering for subscription on November 9, but its premium in the grey market fell significantly after the announcement of issue price band at Rs ...
Published by : moneycontrol.comNovember 9, 2020 9:16:00 AM
The recent geopolitical tension between India and China remains a big risk factor, and may not play out well for Gland Pharma. The ?6,500 IPO of Hyderabad-based Gland Pharma is now open for ...
Published by : Business Insider IndiaNovember 5, 2024 10:27:00 PM
Shares of Gland Pharma soared over 13 percent on November 5 following the company's July-September earnings, which according to brokerages, hint that the worst for the drugmaker might be behind.
Published by : moneycontrol.comNovember 5, 2024 6:13:00 AM
Gland Pharma reported a decline in net profit of ... on November 8 while the listing on November 12. The company set the IPO price band between Rs 28 to Rs 30 per equity share.
Published by : The Financial ExpressNovember 5, 2024 8:58:00 PM
Gland Pharma Q2 Results Live : Gland Pharma declared their Q2 results on 04 Nov, 2024, reporting a topline increase of 2.36% year-over-year, while profit saw a significant decline of 15.74%.
Published by : MintOctober 16, 2024 2:54:00 PM
IPO buzz: 18 out of the top 30 initial public ... SBI Life Insurance Co Ltd, Gland Pharma Ltd, Star Health & Allied Insurance Co Ltd, ICICI Prudential Life Insurance Co Ltd, NHPC Ltd, NTPC Ltd ...
Published by : Live Mint on MSNNovember 5, 2024 5:27:00 AM
While the market closely eyes the US presidential elections, corporate earnings and macroeconomic data will also be on radar ...
Published by : Business StandardNovember 14, 2024 12:25:00 AM
Gland Pharma beat muted expectations for Q2FY25. There was increased Ebitda (Earnings before interest, taxes, depreciation and amortisation) loss at Cenexi, the CRAM subsidiary. Gland Pharma's ...
Published by : rediff.comNovember 5, 2024 2:20:00 PM
Gland Pharma reported a 15.7% YoY decline in net profit to ?163.5 Crore for Q2, ending September 30, 2024, compared to ?194 Crore in the same quarter last year. Revenue from operations rose 2. ...
Published by : India InfolineThe IPO Shares of Gland Pharma Limited IPO are proposed to list on Friday, November 20, 2020 at BSE, NSE. The public issue of Gland Pharma IPO was opened on Nov 9, 2020 and closed for subscription on Nov 11, 2020. Gland Pharma IPO Listing Date and Information:
| Listing Date | Friday, November 20, 2020 |
| BSE Script Code | 543245 |
| NSE Symbol | GLAND |
| Listing In | |
| ISIN | INE068V01023 |
| Issue Price | [.] |
| Face Value | Rs 1 Per Equity Share |
The allotment status of Gland Pharma Limited IPO is now available online. The public issue of Gland Pharma IPO was open on Nov 9, 2020 and closed for subscription on Nov 11, 2020. The equity shares of the company to be list at BSE, NSE.
Gland Pharma Limited is entering in the capital market with an IPO of [.] Equity Shares of Rs 1 aggregating up to Rs [.] Crore. The price for the issue has been set at Rs 1490 - Rs 1500 Per Equity Share.
Gland Pharma Ltd, the Hyderabad-based company is one of the fastest-growing generic injectable companies. It manufactures a diversified range of high-quality complex injectables. The company offers products like sterile injectables, oncology, and ophthalmics, complex injectables (peptides, suspensions, hormonal products, long-acting injectables), NCE-1s, First-to-File products, etc.
The issue opens on Nov 9, 2020 and closes for subscription on Nov 11, 2020. The equity shares of the company to be list at BSE, NSE.
The issue of Gland Pharma Limited opens on Nov 9, 2020 and closes for subscription on Nov 11, 2020. The equity shares of the company to be list at BSE, NSE. The price for the issue has been set at Rs 1490 - Rs 1500 Per Equity Share.
The Gland Pharma IPO is proposed to open on November 9, 2020. The IPO application ends on November 11, 2020.
Retail investors can apply in the retail or non-institutional investor category from November 9, 2020 to November 11, 2020. The Gland Pharma IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Gland Pharma IPO will open for subscription on November 9, 2020. The public issue will close on November 11, 2020.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
